DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Sandborn WJ, Feagan BG, Marano C. et al.
Subcutaneous golimumab maintains clinical response in patients with moderate-to-severe ulcerative colitis.
Gastroenterology 2014;
146: 96-109 e1
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.